Corrigendum to "Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: results from the VEBIS primary care test-negative design study, September 2023-January 2024" [Vaccine 42(19) (2024)]
Vaccine. 2024 Oct 3;42(23):126089.
doi: 10.1016/j.vaccine.2024.06.056.
Epub 2024 Jul 8.
2 National Reference Laboratory for Influenza Virus and Other Respiratory Visuses, Infectious disease department - National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
3 National Centre of Epidemiology, CIBERESP, Carlos III Health Institute, Madrid, Spain.
4 Robert Koch institute, Berlin, Germany.
5 Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
6 National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary.
7 Sorbonne Université, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.
8 Epidemiology Department, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
9 Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain.
10 National Institute for Public Health and the Environment, Centre for Infectious Diseases Control, Bilthoven, the Netherlands.
11 Croatian Institute of Public Health, Zagreb, Croatia.
12 Public Health Agency of Sweden, Stockholm, Sweden.
13 Cantacuzino National Military Medical Institute for Research and Development, Bucharest, Romania.
14 National Reference Centre for Influenza, Robert Koch Institute, Berlin, Germany.
15 UCD-National Virus Reference Laboratory University College Dublin, Dublin, Ireland.
16 Centre National de Référence Virus des Infections Respiratoire (CNR VIR) Institut Pasteur Université Paris Cité, Paris, France; Institut Pasteur, Université Paris-Saclay, Université de Versailles St. Quentin, Université Paris Cité, UMR 1173 (2I), INSERM; Assistance Publique des Hôpitaux de Paris, Paris, France.
17 Nivel, Utrecht, the Netherlands.
18 Bioinformatics Unit, Infectious Diseases Department, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
19 Servicio de Epidemiología de la Consejería de Sanidad y Servicios Sociales de Ceuta, Ceuta, Spain.
20 European Centre for Disease Prevention and Control, Stockholm, Sweden.
21 Epiconcept, Paris, France. Electronic address: e.kissling@epiconcept.fr.